Clinical Trials are Better, Faster, Cheaper with Big Data
What if researchers didn’t need to recruit a control group and could offer the experimental treatment to everyone who agreed to be in the study? In this white paper — developed in partnership with MIT Technology Review — you’ll learn how biotechnology companies are leveraging Medidata’s detailed information from 23,000+ trials and 7 million patients to create external control arms and accelerate the clinical trial process.
Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700 customers and partners access the world’s most-used platform for clinical development, commercial, and real-world data. For more information, visit www.medidata.com/acornai.